Pathogenesis of Benign Prostatic Hyperplasia
Authors
Affiliations
The pathogenesis of benign prostatic hyperplasia (BPH) remains largely unresolved. Three major theories have evolved over the years, each emphasizing a possible causative mechanism. The first theory, the dihydrotestosterone hypothesis, is based on the failure of BPH to develop in men castrated prior to puberty. The second, the embryonic reawakening theory, assumes a reawakening of the embryonic induction potential of prostatic stroma. The third, or stem cell theory, postulates the development of BPH through an increase in the number of stem cells or through an abnormal increase in clonal expansion of amplifying or transit cells. These mechanisms may act in concert.
Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X Res Rep Urol. 2024; 16:205-214.
PMID: 39345801 PMC: 11430843. DOI: 10.2147/RRU.S477396.
Lin J, Zhou J, Xu W, Hong Z, Peng J Exp Ther Med. 2014; 8(1):118-124.
PMID: 24944609 PMC: 4061199. DOI: 10.3892/etm.2014.1723.
Byun H, Sung Y, Kim W, Jung J, Song J, Chul Chung H Korean J Urol. 2012; 53(11):774-8.
PMID: 23185669 PMC: 3502736. DOI: 10.4111/kju.2012.53.11.774.
Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.
Yim S, Cho Y, Joo K Korean J Urol. 2011; 52(6):390-5.
PMID: 21750749 PMC: 3123814. DOI: 10.4111/kju.2011.52.6.390.
Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.
Peters D, Sorkin E Drugs. 1993; 46(1):177-208.
PMID: 7691505 DOI: 10.2165/00003495-199346010-00010.